Molecular Imaging 2017

Q3. Dose-painting trials

A. Could be performed on any valuable metabolic imaging B. Should be performed with

metabolic imaging with a predictive value for post- radiotherapy relapse

C. Require quality control D. Should be widely spread whatever the risk of « killing » the value of a metabolic imaging

0% 0% 0% 0%

A.

B.

C.

D.

MR spectroscopic imaging for dose-painting

34